Canadian Biomarker Integration Network in Depression:
We are participating in the multi-centre CAN-BIND project to investigate biological markers (“biomarkers”, such as blood-based proteins and genes and brain scan images) that predict treatment outcomes in depression.
This study involves gathering biological, physiological, neuropsychological, and clinical information from depressed people and (for comparison) from healthy volunteers. Clinical assessments include standardized, validated measures of general and occupational functioning (including work productivity), before, during, and after treatment. We hope to promote personalized medicine by identifying tests that can predict a specific treatment for a particular person.
For more information, please visit the study website, at www.canbind.ca.